PRM.TO
Price:
$13.84
Market Cap:
$16.83M
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Industry
Asset Management
IPO Date
2017-11-27
Stock Exchange
TSX
Ticker
PRM.TO
According to Big Pharma Split Corp.’s latest financial reports and current stock price. The company's current ROE is -16.89%. This represents a change of 621.73% compared to the average of -2.34% of the last 4 quarters.
The mean historical ROE of Big Pharma Split Corp. over the last ten years is 8.39%. The current -16.89% ROE has changed -301.36% with respect to the historical average. Over the past ten years (40 quarters), PRM.TO's ROE was at its highest in in the December 2019 quarter at 19.40%. The ROE was at its lowest in in the December 2024 quarter at -13.00%.
Average
8.39%
Median
8.38%
Minimum
-3.94%
Maximum
21.66%
Discovering the peaks and valleys of Big Pharma Split Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 976.20%
Maximum Annual ROE = 21.66%
Minimum Annual Increase = -105.53%
Minimum Annual ROE = -3.94%
| Year | ROE | Change |
|---|---|---|
| 2024 | -3.94% | 346.72% |
| 2023 | -0.88% | -105.53% |
| 2022 | 15.94% | -26.41% |
| 2021 | 21.66% | 976.20% |
| 2020 | 2.01% | -87.27% |
| 2019 | 15.82% | 7.21% |
| 2018 | 14.75% | 752.53% |
The current ROE of Big Pharma Split Corp. (PRM.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.71%
5-year avg
6.96%
10-year avg
8.39%
Big Pharma Split Corp.’s ROE is less than Big Banc Split Corp. (31.87%), less than Elysee Development Corp. (27.68%), greater than Nations Royalty Corp. (-69.17%), less than GOAT Industries Ltd. (217.86%), less than Faircourt Gold Income Corp. (30.97%), less than Planet Ventures Inc. (11.48%), less than Sixty Six Capital Inc. (39.31%), greater than SATO Technologies Corp. (-45.29%), greater than RE Royalties Ltd. (-159.62%),
| Company | ROE | Market cap |
|---|---|---|
| 31.87% | $22.40M | |
| 27.68% | $13.87M | |
| -69.17% | $10.45M | |
| 217.86% | $6.90M | |
| 30.97% | $14.85M | |
| 11.48% | $8.17M | |
| 39.31% | $10.19M | |
| -45.29% | $9.16M | |
| -159.62% | $10.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Big Pharma Split Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Big Pharma Split Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Big Pharma Split Corp.'s ROE?
How is the ROE calculated for Big Pharma Split Corp. (PRM.TO)?
What is the highest ROE for Big Pharma Split Corp. (PRM.TO)?
What is the 3-year average ROE for Big Pharma Split Corp. (PRM.TO)?
What is the 5-year average ROE for Big Pharma Split Corp. (PRM.TO)?
How does the current ROE for Big Pharma Split Corp. (PRM.TO) compare to its historical average?